Teva Acquires Respiratory Care Software Platform

Teva Pharmaceutical (NYSE: TEVA) has had a busy year, making four divestitures and four acquisitions. Last week it tipped the balance in favor of acquisitions, with the purchase of privately held Gecko Health Solutions in Cambridge, Massachusetts. Gecko’s CareTRx™ platform is a novel cloud-based solution designed to simplify chronic respiratory disease management, connecting patients and caregivers through remote monitoring and real-time adherence tools. Teva hopes to apply the CareTRx technology to its pipeline and portfolio of respiratory products. Read More »

2015: The Year of the Small Hospital Deal

You may have read the article in The Wall Street Journal on September 22, titled “Health Law Speeds Merger Frenzy.” It featured our data on the pace of hospital M&A between 2009 and August 31, 2015, with the obvious conclusion that 2015 is the winner for the most deals announced in the first eight months. We took that a step further this week, to see how many small hospitals (defined as 100 or fewer beds) have changed hands in recent years. The data below clearly shows that 2015, even with partial data, tops the previous five years with 34 deals (45% of the total) announced with small hospitals as the target. We’ll have more in the October issue of Health Care Deal News, so sign up... Read More »

Agape Senior Living Portfolio Sold

Last week’s largest deal total just $153.8 million. That modest amount was paid by an undisclosed private equity firm to acquire the Agapé Senior Living portfolio across South Carolina. The portfolio consists of 10 assisted living communities, with 856 units, and three skilled nursing facilities, with 294 beds. The buildings were constructed from 1990 to 2008, with various renovations. Occupancy averaged 77.5% at the AL/MC and 81.6% at the SNFs. The final purchase price came out to $156,400 per unit for the AL/MC units and $68,000 per bed for the skilled nursing. Read More »

Signal Bay Buys Cannabis Testing Lab

The medical marijuana market has been growing like a weed, puns intended, but we haven’t logged many deals associated with it because they’re either undisclosed or simply too far afield to qualify. Last week, however, Las Vegas-based Signal Bay Inc. announced its acquisition of Bend, Oregon-based CannAlytical Research, a testing laboratory that is equipped with the latest high-performance liquid chromatography equipment. It provides state-mandated compliance tests for licensed medical marijuana dispensaries. Signal Bay, through its wholly owned subsidiaries Signal Bay Research, Inc. and Signal Bay Services, Inc., provides industry research, consulting, license application support and... Read More »